World's Best Scientists 2026 revealed!
Angus Murray Macleod

Angus Murray Macleod

D-Index & Metrics

Chemistry

D-Index
42
Citations
5912
World Ranking
17582
National Ranking
4296

Angus Murray Macleod publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Angus Murray Macleod sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 132 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Angus Murray Macleod D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Angus Murray Macleod sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 42 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Angus Murray Macleod is affiliated with MSD in the United States and focuses research efforts on chemistry, biochemistry, genetics, molecular biology, and neuroscience. Their work spans several subfields including organic chemistry, molecular biology, cellular and molecular neuroscience, neurology, and physiology, reflecting a multidisciplinary approach to scientific investigation.

Their recent publications cover a range of topics linked to chemical synthesis, pharmacological studies, and neurological disease mechanisms. Notable papers include:

  • Novel Macrocyclic NLRP3 Inhibitors (2024), published in the Journal of Medicinal Chemistry
  • Discovery of ONO-8590580: A novel, potent and selective GABAA α5 negative allosteric modulator for the treatment of cognitive disorders (2020), published in Bioorganic & Medicinal Chemistry Letters
  • PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models (2025), published in Brain

Frequent coauthors in their collaborative work include Kim L. Matthews, Reena Halai, Matthew A. Cooper, Stefanie Mesch, and Jonathan Shannon. Their partnerships reflect repeated collaborative efforts in related research areas.

Common publication venues for their work are:

  • Journal of Medicinal Chemistry
  • Bioorganic & Medicinal Chemistry Letters
  • Brain

The main topics present in Macleod's scientific investigations involve:

  • Synthesis of heterocyclic compounds
  • Synthesis and biological activity
  • Chemical synthesis and pharmacological studies
  • Pharmacological receptor mechanisms and effects
  • Neuroscience and neuropharmacology research
  • Nicotinic acetylcholine receptors study
  • Parkinson's disease mechanisms and treatments

Best Publications

  • An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

    G. R. Dawson;K. A. Maubach;N. Collinson;M. Cobain

  • Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them

    Richard Thomas Lewis;Angus Murray Macleod;Kevin John Merchant

  • Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.

    F.D. Tattersall;W. Rycroft;B. Francis;D. Pearce

  • Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

    John Saunders;Mark Cassidy;Stephen B. Freedman;Elizabeth A. Harley

  • Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

    M. B. Van Niel;I. Collins;M. S. Beer;H. B. Broughton

  • Identification of a Novel, Selective GABAA α5 Receptor Inverse Agonist Which Enhances Cognition

    Mark S. Chambers;John R. Atack;Howard B. Broughton;Neil Collinson

  • Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

    Frank Watjen;Raymond Baker;Mogens Engelstoff;Richard Herbert

  • Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.

    L J Street;R Baker;T Book;C O Kneen

  • Substituted morpholine derivatives and their use as therapeutic agents

    Raymond Baker;Timothy Harrison;Angus Murray Macleod;Andrew Pate Owens

  • An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABAA α5 Receptors with Cognition Enhancing Properties

    Mark S. Chambers;John R. Atack;Robert W. Carling;Neil Collinson

  • Selective, Orally Active γ-Aminobutyric AcidA α5 Receptor Inverse Agonists as Cognition Enhancers

    Francine Sternfeld;Robert W. Carling;Richard A. Jelley;Tamara Ladduwahetty

  • 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.

    M Rowley;D J Hallett;S Goodacre;C Moyes

  • A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ

    Hilde M van der Schaar;Pieter Leyssen;Hendrik Jan Thibaut;Armando De Palma

  • Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.

    M A Cascieri;A M Macleod;D Underwood;L L Shiao

  • Oxadiazoles useful in the treatment of senile dementia

    Raymond Baker;Angus Murray Macleod;Kevin John Merchant;John Saunders

  • Thiadiazoles useful in the treatment of senile dementia

    Raymond Baker;John Saunders;Angus M. Macleod;Kevin Merchant

  • N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists

    Angus M. MacLeod;Kevin J. Merchant;Margaret A. Cascieri;Sharon Sadowski

  • 4-(Phenylsulfonyl)piperidines: Novel, Selective, and Bioavailable 5-HT2A Receptor Antagonists

    Stephen R. Fletcher;Frank Burkamp;Peter Blurton;Susan K. F. Cheng

  • HETEROCYCLIC COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY

    Macleod Angus M

  • Synthesis and Biological Evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and Analogues as Subtype-Selective Inverse Agonists for the GABAAα5 Benzodiazepine Binding Site

    Leslie J. Street;Francine Sternfeld;Richard A. Jelley;Austin J. Reeve

  • Heterocyclic amide derivatives as tachykinin antagonists

    Richard J. Lewis;Angus M. MaCleod;Kevin J. Merchant

Frequent Co-Authors

Raymond Baker
Raymond Baker MSD (United States)
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
John R. Atack
John R. Atack Cardiff University
Gerard R. Dawson
Gerard R. Dawson P1vital LTD
Keith A. Wafford
Keith A. Wafford Eli Lilly (United States)
Ruth M. McKernan
Ruth M. McKernan MSD (United States)
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Richard G. Ball
Richard G. Ball MSD (United States)
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Peter W. Hunt
Peter W. Hunt University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of career paths, some of which can be further enhanced through related online degrees. For those interested in legal aspects of chemistry, such as patent law or environmental regulations, exploring an online associate degree in criminal justice can provide foundational knowledge that complements a chemistry background.

Additionally, careers such as becoming a paralegal may require specific qualifications. Understanding the different types of paralegals and their educational pathways can help chemistry graduates diversify their skill set in legal and regulatory fields.

Pharmaceutical sales is another lucrative option. Chemistry graduates can leverage their scientific expertise to excel in this field, where knowledge of drug composition and effects is key. For insights, check the information on pharmaceutical sales rep salary and career paths.

For those interested in more clinical roles, becoming a pharmacist is a natural extension of chemistry studies. The process and requirements on how do you become a pharmacist offer valuable guidance to plan this career transition effectively.

Best Scientists Citing Angus Murray Macleod

Trending Scientists

Recently Published Articles